Atrium C-Qur hernia mesh lawsuit MDL 2753: how the substantially-completing settlement framework actually works

The Atrium Medical Corporation C-Qur Mesh litigation under MDL 2753 (In re: Atrium Medical Corp. C-Qur Mesh Products Liability Litigation), pending in the U.S. District Court for the District of New Hampshire before Chief Judge Landya B. McCafferty, represents one of the substantially-completing hernia mesh mass torts. The substantial litigation against Atrium Medical Corporation (subsidiary of Getinge Group) has substantially resolved through substantial multi-year settlement framework with substantial confidential settlement amounts. As of February 2026, the MDL has approximately 246 pending cases (down from substantial peaks of 620 cases in November 2024 and earlier substantial totals of 2,500+ cases). Approximately 3,574 total cases were filed in MDL 2753 since its substantial 2016 establishment. The substantial settlement framework substantially provides estimated $60,000-$100,000 per case range — substantial framework that substantially distinguishes Atrium's resolution from substantially larger Bard hernia mesh framework.

The substantive theory centers on the substantial defective design and manufacturing of Atrium's C-Qur Mesh, a polypropylene-based hernia repair mesh product with substantial omega-3 fatty acid coating. The substantial substantive product was substantially recalled by FDA in 2013 — substantial regulatory action after substantial discovery that the substantial mesh would substantially adhere to the substantial package liner when exposed to substantial high humidity. The substantial substantive defect theory centers on substantial multiple substantive problems including substantial inadequate manufacturing processes, substantial design defects in the substantial omega-3 fatty acid coating allegedly substantially causing substantial inflammatory response and substantial adhesion to substantial surrounding tissue and organs, substantial inadequate sterility framework, and substantial substantive failure to warn substantial physicians and patients about substantial complications. The substantial substantive failure pattern substantially produced substantial hernia recurrence, substantial revision surgery requirement, substantial chronic pain, substantial bowel obstruction, substantial adhesion-related complications, and substantial fistula formation in substantial affected patients.

The substantial settlement framework substantially resolved over multiple years through substantial confidential settlement framework. In substantial 2021, Atrium Medical (through substantial parent Getinge Group) substantially agreed to substantial $66 million settlement framework for substantial C-Qur mesh lawsuits. In October 2024, Chief Judge McCafferty substantially approved substantial settlement plan in substantial MDL 2753 with substantial Milestone substantially administering the substantial settlement fund. Atrium continues to settle remaining cases through substantial confidential framework with substantial estimated $60,000-$100,000 per case range. The substantial substantive procedural framework substantially provides substantial bellwether trial outcomes through 2024-2025 that substantially shaped substantial settlement valuations. The substantial winding-down framework substantially continues through 2026 with substantial residual cases substantially proceeding through substantial streamlined case management framework. Substantial Atrium ProLite and ProLoop mesh products substantially remain on market despite substantial allegations of substantial design defects — substantial separate litigation framework continues.

This is how the Atrium C-Qur hernia mesh litigation actually works through MDL 2753, the substantive theory of the substantial C-Qur product defects, the substantial 2013 FDA recall framework, the substantial multi-year settlement framework with substantial $66 million 2021 framework and substantial October 2024 settlement plan approval, the substantial winding-down procedural framework, and the strategic considerations for affected patients understanding the substantial substantively-resolving framework.

What the Atrium C-Qur product was and the alleged defects

The Atrium C-Qur products at issue:

Atrium C-Qur Mesh. Substantial:

Polypropylene-based hernia mesh
Omega-3 fatty acid coating
Substantial substantive design
2013 FDA recall
Substantial substantive defect theory

Substantial design framework:

Polypropylene mesh. Substantial:

Synthetic material
Substantial hernia repair use
Substantial substantive design
Substantial substantive analysis

Omega-3 fatty acid coating. Substantial:

Substantial substantive purpose: reduce adhesions
Substantial substantive failure pattern alleged
Substantial inflammatory response
Substantial substantive defect theory

Substantial product line:

C-Qur (subject of MDL 2753)
C-Qur Edge
C-Qur V-Patch
Substantial substantive variants
Substantial substantive framework

Substantial alleged defects:

1. 2013 FDA Class 2 recall. Substantial:

Mesh adhered to package liner in high humidity
Substantial substantive regulatory action
Substantial substantive product integrity concern
Substantial procedural framework

2. Inflammatory response from omega-3 coating. Substantial:

Substantial substantive defect
Substantial substantive complications
Substantial substantive analysis

3. Substantial adhesion formation. Substantial:

Substantial adhesions to surrounding tissue/organs
Substantial substantive complications
Substantial substantive defect
Substantial subsequent surgical complications

4. Substantial inadequate sterility framework. Substantial:

Substantial substantive concerns
Substantial substantive defect
Substantial substantive analysis

5. Substantial material degradation. Substantial:

Substantial substantive defect
Substantial substantive analysis

6. Substantial mesh shrinkage. Substantial:

Substantial substantive defect pattern
Substantial subsequent complications
Substantial substantive analysis

7. Substantial mesh migration. Substantial:

Movement from intended position
Substantial substantive complications
Substantial substantive defect

8. Substantial failure to warn. Substantial:

Substantial substantive theory
Substantial substantive product liability
Substantial individual analysis

The alleged injuries

Plaintiffs in MDL 2753 allege various injuries:

Substantial hernia recurrence. Substantial:

Most common substantial complication
Substantial subsequent surgical intervention
Substantial documentation requirement
Substantial substantive framework

Substantial revision surgery requirement. Substantial:

Subsequent operations to remove mesh
Substantial complex surgical procedures
Substantial recovery period
Substantial functional impact

Substantial chronic pain. Substantial:

Persistent abdominal pain
Substantial daily life impact
Substantial subsequent medical care
Substantial individual analysis

Substantial bowel obstruction. Substantial:

Mesh-related obstruction
Substantial complications
Substantial emergency intervention
Substantial substantive complications

Substantial adhesion-related complications. Substantial:

Adhesions to bowel, organs
Substantial complications
Substantial subsequent intervention required

Substantial infection. Substantial:

Mesh-related infections
Substantial subsequent complications
Substantial substantive analysis

Substantial fistula formation. Substantial:

Substantial complications
Substantial subsequent intervention
Substantial substantive analysis

Substantial wrongful death cases. Some:

Substantial complications causing death
Substantial substantive framework
Substantial state law variation

The procedural history of MDL 2753

The litigation developed through several phases:

2007-2013. Substantial market introduction and clinical use of C-Qur.

2013. Substantial FDA Class 2 recall:

Mesh adhering to package liner in high humidity
Substantial regulatory action
Substantial substantive framework
Substantial substantive product integrity concern

2013-2016. Substantial lawsuit filing begins. Substantial individual lawsuits filed.

December 2016. Judicial Panel on Multidistrict Litigation establishes MDL 2753 in D. New Hampshire. Chief Judge Landya B. McCafferty assigned.

2017-2020. Substantial discovery and motion practice. Substantial individual case development.

Substantial 2018. Substantial bellwether case management framework. Substantial substantive trial preparation.

Substantial 2019-2021. Substantial bellwether trials and settlement negotiations.

Substantial 2021. Atrium Medical (through Getinge Group) substantially agreed to substantial $66 million settlement:

Substantial substantive framework
Substantial confidential individual settlements
Substantial procedural framework

Substantial 2022-2023. Substantial individual case settlements continue.

October 2024. Chief Judge McCafferty substantially approved substantial settlement plan:

Substantial substantive framework
Milestone substantially administering settlement fund
Substantial procedural framework

November 1, 2024. 620 cases pending. 3,574 total cases filed in MDL.

February 2026. 246 pending cases:

Substantial winding-down
Substantial substantive framework
Substantial individual analysis

May 2026. 184 active lawsuits (per recent reports):

Substantial winding-down continues
Substantial procedural framework
Substantial substantive resolution approaching

The substantial settlement framework

Settlement framework structure

Substantial substantive framework:

$66 million 2021 framework. Substantial:

Substantial substantive framework
Substantial confidential individual settlements
Substantial procedural framework

October 2024 settlement plan. Substantial:

Chief Judge McCafferty approval
Milestone administering settlement fund
Substantial procedural framework
Substantial substantive resolution

Substantial substantive case factors:

Specific injury severity. Substantial:

Substantial individual factors
Substantial substantive evaluation
Substantial procedural framework

Substantial complications. Substantial:

Multiple revisions
Substantial complications
Substantial substantive analysis

Substantial functional impact. Substantial:

Substantial individual factors
Substantial substantive evaluation

Substantial wrongful death. Substantial:

Substantial state law variation
Substantial substantive framework

Substantial estimated settlement range

Substantial substantive framework:

Estimated $60,000-$100,000 per case (substantial range varies). Substantial:

Substantial substantive framework
Substantial individual evaluation
Substantial professional involvement valuable

Substantial procedural framework continuing

Substantial substantive framework:

Substantial winding-down framework. Substantial:

Residual cases continuing through 2026
Substantial streamlined case management
Substantial procedural framework
Substantial substantive resolution approaching

Substantial broader hernia mesh litigation framework

The substantial hernia mesh litigation includes substantial other manufacturers:

Bard/Davol MDL 2846:

S.D. Ohio
~23,728 pending cases (Feb 2026)
Substantial active framework
January 2026 substantial settlement announcement (BD substantial resolution)
Substantial procedural framework

Atrium C-Qur MDL 2753:

D. New Hampshire
~246 pending cases (Feb 2026)
Substantial winding down
Substantial substantive framework

Covidien MDL 3029:

D. Massachusetts
~2,260 pending cases (Feb 2026)
Substantial active framework
Substantial bellwether trials approaching

Ethicon Physiomesh MDL 2782:

N.D. Georgia
0 pending cases (Feb 2026)
Substantially completed
Substantial substantive framework

Substantial substantive framework:

Different manufacturers
Different mesh products
Different procedural posture
Substantial individual analysis

Eligibility framework

For prospective plaintiffs (substantially limited at this point):

Documenting Atrium C-Qur implantation

Critical first step. Identify specific product:

Surgical records (operative report)
Hospital records identifying specific mesh
Manufacturer identification (Atrium Medical specifically)
Product identification (C-Qur Mesh specifically — distinguishing from Atrium ProLite/ProLoop)
Lot numbers and serial numbers
Substantial product-specific identification

Important note. Many hernia mesh products:

Atrium C-Qur (this litigation — substantially winding down)
Atrium ProLite (substantial separate framework)
Atrium ProLoop (substantial separate framework)
Ethicon Physiomesh (MDL 2782 — substantially completed)
Bard/Davol products (MDL 2846 — active)
Covidien Parietex (MDL 3029 — active)
Various other manufacturer products

The specific manufacturer determines which litigation framework applies.

Documenting the injury

Strong case requirements:

Imaging documentation:

CT scans showing recurrence
MRI for mesh evaluation
Substantial radiological evidence

Specific injury types:

Hernia recurrence
Revision surgery requirement
Chronic pain
Adhesions
Bowel obstruction
Infection
Substantial complications

Treatment records:

Revision surgery records
Complications during revision
Subsequent medical treatment
Pain management
Functional limitations
Pathology of removed mesh (substantial)

Substantial connection to C-Qur:

Medical evaluation supporting causation
Treating physician statements
Pathology of removed mesh
Substantial documentation of connection

Statute of limitations analysis

Most states have 2-4 year limitations from injury or discovery:

Discovery rule may apply
Substantial individual variation
Specific state law analysis required
Substantial counsel evaluation needed

Substantial Atrium statute of limitations defenses raised. Substantial:

Statute of limitations as defense
Substantial individual analysis required
Substantial counsel involvement valuable

How Atrium C-Qur litigation compares to other hernia mesh frameworks

The framework has distinctive features:

Compared to Bard hernia mesh MDL 2846: Bard ~23,728 cases pending (substantial active framework with substantial January 2026 BD settlement framework). Atrium ~246 cases (substantial winding down). Substantial substantive distinction.

Compared to Ethicon Physiomesh MDL 2782: Ethicon substantially completed (0 cases). Atrium substantially winding down (246 cases). Both have substantial substantive completion patterns.

Compared to Covidien MDL 3029: Covidien substantial bellwether trials approaching with 2,260 cases. Atrium substantially settled framework.

Compared to Cook IVC filter MDL 2570: Cook partial settlement framework. Atrium substantially completing framework.

Compared to Bard IVC filter MDL 2641: Both substantially settled. Bard IVC: 8,000+ cases settled May 2019. Atrium C-Qur: 3,574 total cases substantially settled 2021-2026.

Compared to Wright Profemur: Both substantial multi-year settlement frameworks. Wright: $330 million across two settlements. Atrium: $66 million 2021 framework plus subsequent settlements.

Distinctive Atrium C-Qur features:

Substantially winding-down (246 cases Feb 2026)
3,574 total cases over MDL lifetime
2013 FDA Class 2 recall (mesh adhering to package liner in high humidity)
$66 million 2021 settlement framework
October 2024 substantial settlement plan approval
Milestone administering settlement fund
Estimated $60,000-$100,000 per case
Chief Judge Landya B. McCafferty
Atrium Medical Corporation defendant (subsidiary of Getinge Group)
Polypropylene mesh with omega-3 fatty acid coating
Substantial product line (C-Qur, C-Qur Edge, C-Qur V-Patch)
Separate Atrium ProLite and ProLoop framework continues
Substantial winding-down procedural framework
Substantial professional limitation for new cases

Settlement projections

Settlement valuation:

Substantial procedural framework:

$66 million 2021 settlement framework
Substantial confidential individual settlements
October 2024 substantial settlement plan approval
Substantial individual evaluation

Estimated settlement ranges:

Severe complication cases:

Multiple revisions
Substantial complications
Substantial bowel involvement
Range: $80,000 - $200,000+
Wrongful death cases potentially higher

Moderate complication cases:

Single revision
Substantial complications
Substantial functional impact
Range: $40,000 - $100,000

Less severe cases:

Revision required
Limited subsequent complications
Substantial documented harm
Range: $20,000 - $80,000

Wrongful death cases:

Substantial state law variation
Range varies dramatically by state
Substantial individual case factors

Tax implications. Personal injury settlements for physical injuries are tax-free under IRC §104(a)(2). Coordinate with tax counsel for substantial settlements, particularly when other tax debt issues or §72(t) early withdrawal considerations exist.

Strategic considerations

For affected patients with documented Atrium C-Qur implantation:

Identify Atrium C-Qur implantation specifically. Critical first step:

Surgical records
Hospital identification
Manufacturer verification (Atrium Medical specifically)
Product model identification (C-Qur Mesh specifically — distinguishing from Atrium ProLite/ProLoop products with substantial separate frameworks)
Distinguish from Bard, Ethicon, Covidien, or other manufacturer products
Substantial documentation requirement

Address the substantial winding-down framework. Substantial:

MDL 2753 substantially winding down
Substantial procedural framework approaching completion
Substantial individual analysis required
Substantial professional involvement valuable

Document the injury comprehensively. Strong cases include:

Imaging studies (CT, MRI)
Treatment records
Revision surgery records
Pathology of removed mesh
Treating physician opinions
Functional impact documentation

Address the statute of limitations carefully. Atrium raises substantial defenses:

2-4 year periods in most states
Discovery rule applicability
Specific state law analysis
Some delayed discovery cases viable
Substantial counsel evaluation needed

Engage experienced hernia mesh counsel. Substantial procedural complexity:

Substantial settlement plan framework
Substantial procedural framework
Statute of limitations defenses
Substantial firm-specific Atrium C-Qur experience valuable

Watch related hernia mesh frameworks if applicable. Substantial:

Different manufacturers
Bard substantial active framework
Ethicon substantially completed
Covidien substantial bellwether trials approaching
Substantial coordination considerations
Substantial individual analysis

Plan for state court alternatives if available. Substantial:

Some cases may proceed in state courts
Substantial procedural framework
Substantial state-specific law
Substantial counsel coordination

Document subsequent medical treatment. Strong cases include:

All medical care related to mesh
Revision surgery documentation
Complication treatment
Ongoing pain management
Functional impact

Coordinate with treating physicians. General surgeons and other treating physicians are important witnesses. Their assessment of causation strengthens cases.

Plan for the substantial growth loss when accessing retirement funds. Some plaintiffs:

Need retirement funds for medical expenses
§72(t) early withdrawal substantial cost
Substantial coordination required
May benefit from medical expense exception

Address related tax planning. Personal injury settlements for physical injuries are tax-free. Coordinate with tax counsel for substantial settlements. Component allocation (physical injury vs. emotional distress) affects tax treatment.

Watch the wrongful death framework. Some severe cases:

Bowel obstruction
Substantial complications
Substantial state law variation
Estate has standing
Surviving family members may have separate claims

Document the lifestyle impact. Strong cases show:

Pre-implantation functional baseline
Loss of function post-implantation
Inability to return to work
Recreational activity loss
Daily life impact

Address the multiple hernia mesh manufacturer landscape carefully. Many manufacturers:

Atrium C-Qur (this litigation — substantially winding down)
Atrium ProLite/ProLoop (substantial separate framework continues)
Bard/Davol products (MDL 2846 — active)
Ethicon Physiomesh (MDL 2782 — substantially completed)
Covidien Parietex (MDL 3029 — active)
Various other manufacturer products

Identify specific manufacturer; substantially different procedural framework for each.

Watch for the 2013 FDA recall substantive significance:

Substantial regulatory action
Substantial substantive product integrity concern
Substantial procedural framework
Substantial substantive impact

Coordinate with LLC asset protection if substantial business assets at risk. Substantial settlements may affect:

Business asset planning
Estate planning
Substantial coordination required

Use the substantial settlement framework. Substantial:

$66 million 2021 framework
October 2024 substantial settlement plan
Substantial individual case framework
Substantial leverage from MDL completion

Plan for substantial Getinge Group corporate framework. Substantial:

Substantial corporate financial capacity
Substantial substantive framework
Substantial procedural framework

Address the time-sensitive nature. Substantial:

Statute of limitations running
Substantial individual deadlines
Substantial counsel evaluation needed
Substantial procedural framework

Plan substantial revision surgery documentation:

Surgical reports
Pathology of removed mesh
Substantial medical documentation
Substantial procedural framework

Coordinate with substantial state court alternatives:

Substantial procedural framework
Substantial state-specific law
Substantial individual analysis
Substantial counsel coordination

Document substantial 2013 FDA recall evidence:

Substantial regulatory action
Substantial substantive evidence
Substantial procedural framework
Substantial substantive analysis

Plan for substantial residual case framework:

Substantial winding-down framework
Substantial procedural framework
Substantial individual analysis

Watch for substantial omega-3 fatty acid coating issue documentation:

Substantial substantive defect theory
Substantial substantive evidence
Substantial procedural framework
Substantial substantive analysis

Address substantial Atrium ProLite/ProLoop framework separately if applicable:

Substantial separate framework
Substantial individual analysis
Substantial procedural framework
Substantial professional involvement valuable

For affected patients with documented Atrium C-Qur hernia mesh injuries, the framework provides substantial historical paths to compensation through the substantial settled MDL 2753 framework that substantially resolved through the substantial $66 million 2021 settlement framework (Atrium Medical's parent Getinge Group substantial substantive resolution) and the substantial October 2024 settlement plan approval by Chief Judge Landya B. McCafferty (with substantial Milestone administering the substantial settlement fund) covering substantial 3,574 total cases over the substantial MDL lifetime since substantial December 2016 establishment. The substantial substantive theory — that the substantial Atrium C-Qur Mesh design with substantial polypropylene mesh and substantial omega-3 fatty acid coating substantially failed through substantial inflammatory response, substantial adhesion formation, substantial inadequate sterility framework, and substantial 2013 FDA Class 2 recall (substantial regulatory action after substantial discovery that mesh substantially adhered to substantial package liner when exposed to substantial high humidity) — substantially demonstrates the substantial substantive defect framework that drove the substantial settlement framework with substantial confidential settlement amounts in the substantial estimated $60,000-$100,000 per case range. With approximately 246 pending cases as of February 2026 (down from substantial peaks of 620 in November 2024 and earlier substantial totals of 2,500+ cases), the substantial procedural framework substantially provides substantial winding-down framework with substantial residual cases substantially proceeding through substantial streamlined case management process. The work for affected patients is in comprehensive product identification through surgical records (verifying specifically Atrium C-Qur Mesh rather than Atrium ProLite/ProLoop products with substantial separate continuing frameworks, or Bard/Davol products, Ethicon Physiomesh, Covidien Parietex, or other manufacturer products with substantial professional analysis given the substantial winding-down procedural framework of MDL 2753), thorough injury documentation including imaging studies (CT, MRI) and revision surgery records with substantial pathology of removed mesh, engagement with experienced hernia mesh counsel familiar with both the substantial Atrium C-Qur settlement framework and the substantial related active Bard, Atrium ProLite/ProLoop, and Covidien frameworks along with the substantial statute of limitations issues, substantial professional analysis of whether viable claims remain available given the substantial winding-down procedural framework of the substantial Atrium C-Qur litigation, and substantial individual case analysis given the substantial substantive completion approaching for substantial residual cases through the substantial substantively-resolving framework administered through substantial Milestone settlement fund framework under substantial Chief Judge McCafferty's substantial October 2024 settlement plan approval framework.